CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo. (Q39175682)
Jump to navigation
Jump to search
scientific article published on 12 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo. |
scientific article published on 12 June 2014 |
Statements
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo (English)
Simona Piaggi
Alessandro Antonelli
Guido Bocci
Silvia Martina Ferrari
Alda Corrado
Anna Fioravanti
Paola Orlandi
Alessandro Corti
Gabriele Materazzi
David Galleri